Eubiotic effects of rifaximin are associated with reduced abdominal pain in symptomatic uncomplicated diverticular disease: results of an observational cohort study | BMC Gastroenterology
To our knowledge, this study is the first to evaluate the long-term (i.e., 6 months) effects of rifaximin on the gut microbiota of SUDD patients. Here we show that rifaximin significantly reduced the severity of abdominal pain, which is consistent with previous studies. [9,10,11,12]. Treatment with rifaximin over 6 months was not associated with significant […]
Interim results of a study using non-invasive wireless
MOUNTAIN VIEW, Calif., May 9, 2023 (GLOBE NEWSWIRE) — G-Tech Medical, a developer of non-invasive diagnostic solutions for gastrointestinal patients, announced today, May 9, 2023, Mountain View, Calif. I gave a poster presentation at the Digestive Disease Week annual meeting held at . Chicago from May 6th to May 9th. Wireless patch reveals differences in […]